Piracetam diminishes hippocampal acetylcholine levels in rats.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Life Science

• Publication date

  1981-03-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0024-3205(81)90685-8PMID 7231039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropharmacological consequences of choline administration

  1980cited by this paper
• Choline chloride effects on memory: correlation with the effects of physostigmine.

  1980cited by this paper
• Age-related changes in passive avoidance retention: modulation with dietary choline.

  1980cited by this paper
• Neuropharmacological consequences of choline administration.

  1980cited by this paper
• Hippocampus, space, and memory

  1979cited by this paper
• Lecithin consumption increases acetylcholine concentrations in rat brain and adrenal gland.

  1978cited by this paper
• Memory and cognitive function in man

  1977cited by this paper
• Necropsy evidence of central cholinergic deficits in senile dementia.

  1977cited by this paper
• Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

  1976cited by this paper
• Increase in the power of human memory in normal man through the use of drugs

  1976cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Brain acetylcholine: increase after systemic choline administration.

  1975cited by this paper
• THE DETERMINATION OF PICOMOLE AMOUNTS OF ACETYLCHOLINE IN MAMMALIAN BRAIN

  1973cited by this paper

• Zebrafish models for studying cognitive enhancers.

  2024cites this paper
• Effects of Ficus umbellata (Moraceae) Aqueous Extract and 7-Methoxycoumarin on Scopolamine-Induced Spatial Memory Impairment in Ovariectomized Wistar Rats

  2018cites this paper
• Scopolamine-based pharmacological MRI model for testing procognitive agents

  2016cites this paper
• Beneficial effect of Brahmi Ghrita on learning and memory in normal rat

  2014cites this paper
• Anxiolytic and Antidepressant Activity of Processed Shilajatu

  2013cites this paper
• Role of piracetam on cognitive function in epilepsy and with antiepileptics in rats

  2013cites this paper
• Cognitive effects of Subacute treatment with Topiramate and Piracetam in Healthy Rats

  2012cites this paper
• Psychopharmacology tomorrow : 1984 or The Little Prince ! }

  2008cites this paper
• Piracetam: a review of pharmacological properties and clinical uses.

  2006cites this paper
• An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers

  2004cites this paper
• Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice

  2004cites this paper
• The effects of piracetam on cognitive performance in a mouse model of Down's syndrome.

  2002cites this paper
• [Treatment of Alzheimer's disease].

  2002cites this paper
• Nootropics And Foods

  1999cites this paper
• Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat.

  1999cites this paper
• New Antiepileptic Drugs

  1999cites this paper
• Piracetam Improves Cognitive Performance by Restoring Neurochemical Deficits of the Aged Rat Brain

  1999cites this paper
• Drugs that increase intelligence?: Application for childhood cognitive impairment

  1998cites this paper
• Pharmacological Properties of Piracetam

  1998cites this paper
• Piracetam

  1998cites this paper
• The brain cholinergic system as a target of cognition enhancers.

  1997cites this paper
• Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.

  1995cites this paper
• Aniracetam improves behavioural responses and facilitates signal transduction in the rat brain

  1994cites this paper
• New Antiepileptic Drugs

  1994cites this paper
• Piracetam and other structurally related nootropics.

  1994cites this paper
• Dopaminergic involvement in the effects of piracetam on foot shock induced aggression in mice.

  1993cites this paper
• Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents

  1993cites this paper
• Oxiracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo

  1993cites this paper
• Effect of piracetam administration on 3H-N-methylscopolamine binding in cerebral cortex of young and old rats.

  1992cites this paper
• Effects of oxiracetam on neurotransmitter release from rat hippocampus slices and synaptosomes.

  1992cites this paper
• Oxiracetam prevents haloperidol-induced passive avoidance impairment in mice.

  1992cites this paper
• Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.

  1992cites this paper
• Effects of oxiracetam-nicotine combinations on active and passive avoidance learning in mice.

  1991cites this paper
• Effects of piracetam on the dexamethasone suppression test in Alzheimer's and multi-infarct dementias

  1991cites this paper
• Diagnostic and Pharmacological Approaches in Alzheimer’s Disease

  1991cites this paper
• Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice.

  1990cites this paper
• Involvement of a steroidal component in the mechanism of action of piracetam-like nootropics.

  1990cites this paper
• [The influence of piracetam on the effects of narcotic analgesics].

  1990cites this paper
• The acute and chronic administrations of piracetam affect the movement-related brain macropotentials.

  1990cites this paper
• Shuttle-box avoidance facilitation by minaprine in mice.

  1990cites this paper
• Avoidance facilitation by nootropics.

  1989cites this paper
• The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.

  1989cites this paper
• Action of piracetam and clonidine on different mitochondrial populations from hippocampus.

  1989cites this paper
• Effect of drugs acting on monoaminergic and cholinergic systems on the quantified EEG of rats.

  1989cites this paper
• Facilitation of calcium-dependent cholinergic function by ucb L059, a new "second generation" nootropic agent.

  1989cites this paper
• A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam.

  1989cites this paper
• Nootropic drugs and brain cholinergic mechanisms

  1989cites this paper
• Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?

  1989cites this paper
• Randomized placebo-controlled double-blind cross-over study on antihypoxidotic effects of piracetam using psychophysiological measures in healthy volunteers.

  1988cites this paper
• Nutrition and Childhood Neuropsychological Disorders

  1988cites this paper
• Chronic Treatment with Piracetam Elevates Muscarinic Cholinergic Receptor Density in the Frontal Cortex of Aged Mice

  1988cites this paper
• Facilitating effect of oxiracetam and piracetam on acquisition of discrete two-way shuttle avoidance in normal mice.

  1988cites this paper
• Restoration of age-related receptor deficits in the central nervous system, a common mechanism of nootropic action?

  1988cites this paper
• Cognitive Enhancing Agents: Current Status in the Treatment of Alzheimer's Disease

  1988cites this paper
• Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice.

  1988cites this paper
• Effects of piracetam on single central neurons.

  1988cites this paper
• Die Wiederherstellung altersbedingter Rezeptordefizite im zentralen Nervensystem, ein gemeinsamer Mechanismus der Nootropikawirkung?

  1988cites this paper
• New Pharmacological Perspectives on Nootropic Drugs

  1988cites this paper
• Piracetam in the treatment of different types of myoclonus.

  1988cites this paper
• Facilitatory effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission.

  1987cites this paper
• Effect of combined or separate administration of piracetam and choline on learning and memory in the rat

  1987cites this paper
• Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.

  1987cites this paper
• Cholinergic dysfunction in Alzheimer disease: cause or effect?

  1986cites this paper
• [Cholinergic treatment strategies in Alzheimer's disease].

  1986cites this paper
• Antimyoclonic action of piracetam.

  1986cites this paper
• Piracetam combined with lecithin in the treatment of Alzheimer's disease.

  1986cites this paper
• Zur Behandlung primär degenerativer Hirnerkrankungen im Alter

  1986cites this paper
• Effect of Oxiracetam and Piracetam on Central Cholinergic Mechanisms and Active‐Avoidance Acquisition

  1986cites this paper
• Avoidance facilitation in adult mice by prenatal administration of the nootropic drug oxiracetam.

  1986cites this paper
• Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesia.

  1986cites this paper
• Effects of Oxiracetam on Learning and Memory in Animals: Comparison with Piracetam

  1986cites this paper
• Animal Behavioral Models in the Discovery of Compounds To Treat Memory Dysfunction

  1985cites this paper
• Clinical Evaluation of Compounds for the Treatment of Memory Dysfunction

  1985cites this paper
• Neurochemical studies on GABAergic and aminergic systems in the rat brain following acute and chronic piracetam administration.

  1985cites this paper
• Improvement of avoidance acquisition by the nootropic drug oxiracetam in mice.

  1985cites this paper
• Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons.

  1985cites this paper
• Interaction of choline and scopolamine in human memory.

  1985cites this paper
• A unified theory of presynaptic chemical neurotransmission.

  1985cites this paper
• Development of cholinergic drugs for the treatment of Alzheimer's disease

  1985cites this paper
• Perspective in the Treatment of Dementia

  1984cites this paper
• Immune diagnosis of a subset of Alzheimer's disease with preliminary implications for immunotherapy.

  1984cites this paper
• Psychopharmacology tomorrow: 1984 or The Little Prince?

  1984cites this paper
• Is Alzheimer's disease an immunological disorder? Observations and speculations.

  1984cites this paper
• Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging.

  1984cites this paper
• Therapeutische Konzepte bei verschiedenen Demenzformen

  1984cites this paper
• Physiological disposition of oral piracetam in Sprague‐Dawley rats

  1984cites this paper
• Effect of piracetam plus choline treatment on hippocampal rhythmic slow activity (RSA) and behavior in rabbits.

  1984cites this paper
• Habituation of exploratory activity in mice: effects of combinations of piracetam and choline on memory processes.

  1984cites this paper
• The cholinergic treatment strategy in aging and senile dementia.

  1983cites this paper
• Some neurochemical properties of pramiracetam (CI‐879), a new cognition‐enhancing agent

  1983cites this paper
• Neurotransmitter Deficits in Alzheimer's Disease: Criteria for Significance

  1983cites this paper
• Piracetam modifies morphine and related drug-induced elevation of serum corticosterone concentration in rats.

  1983cites this paper
• Neuropharmacology of degenerative diseases associated with aging

  1983cites this paper
• The use of cholinergic precursors in neuropsychiatric diseases.

  1982cites this paper
• Potential Therapies in Aging and Senile Dementias *

  1982cites this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cites this paper
• Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats.

  1981cites this paper